Marion Kiechle
TUM Klinikum(DE)Klinikum rechts der Isar(DE)Frauenklinik der Technischen Universität München(DE)Klinik für Frauenheilkunde(DE)Technical University of Munich(DE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Breast Implant and Reconstruction, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology
Most-Cited Works
- → Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene(2010)731 cited
- → Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers(2009)309 cited
- → CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer(2016)262 cited
- → Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer(2016)222 cited
- Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).(2002)
- → A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC(1999)173 cited